K220493 is an FDA 510(k) clearance for the Plaxpot Multi Plasma, a Low Power Electrosurgical Devices For Skin Lesion Destruction (Class II — Special Controls, product code QVJ), submitted by Gcs Co. Limited (Seongnam, KR). The FDA issued a Cleared decision on October 27, 2023, 612 days after receiving the submission on February 22, 2022. This device falls under the General & Plastic Surgery review panel. Regulated under 21 CFR 878.4400.
| 510(k) Number | K220493 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | February 22, 2022 |
| Decision Date | October 27, 2023 |
| Days to Decision | 612 days |
| Submission Type | Traditional |
| Review Panel | General & Plastic Surgery (SU) |
| Summary | Summary PDF |
| Product Code | QVJ — Low Power Electrosurgical Devices For Skin Lesion Destruction |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 878.4400 |
| Definition | For The Removal And Destruction Of Skin Lesions In General Dermatological Procedures, Also Referred To As Plasma Pen Devices, Which Generates Electrical Arc In The Ambient Air Between An Electrical Probe Tip And The Skin And Cause Intended Tissue Damage For The Removal And Destruction Of Skin Lesions |